Event Calendar
Prev MonthPrev Month Next MonthNext Month
The Why & How of Selling/Buying in Healthcare Divestitures
Wednesday, January 23, 2019, 12:00 PM - 1:00 PM EDT
Category: HBSHAA Webinar


A discussion on the acquisition and divestiture processes and landscape for strategics and private equity. Hear from the experts on how they do it:
  • Bain Capital surprises with the creation of a $350M neuro startup with Pfizer assets
  • Johnson & Johnson acquires Actelion, Synthes, divests Cordis, LifeScan Diabetes
  • EY advises of 100s of healthcare transactions

Chris GordonGlobal Head of Healthcare Investing, Bain Capital Private Equity. His many deals include the recent innovative creation of a $350m neuro start-up with Pfizer assets

Kendall O’Brien,
Enterprise VP for Acquisitions and Divestitures, Johnson & Johnson. Created the enterprise capability to provide functional expertise to all Acquisitions and Divestitures

Jeff Wray,
Managing Director EY. Experience across a wide range of transactions

Peter Stebbins, VP, Business Development, J&J Medical Device. Both buy-side and sell-side


Contact: [email protected]